Marta Cano1, Erik Lee1, Narcís Cardoner1, Ignacio Martínez-Zalacaín1, Jesús Pujol1, Nikos Makris1, Michael Henry1, Esther Via1, Rosa Hernández-Ribas1, Oren Contreras-Rodríguez1, José M Menchón1, Mikel Urretavizcaya1, Carles Soriano-Mas1, Joan A Camprodon1. 1. From the Department of Psychiatry, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona (MC, IM-Z, RH-R, OC-R, JMM, MU, CS-M); the Department of Clinical Sciences, School of Medicine, University of Barcelona (MC, IM-Z, RH-R, JMM, MU); CIBERSAM, Carlos III Health Institute, Madrid (MC, NC, JP, EV, RH-R, OC-R, JMM, MU, CS-M); the Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (MC, EL, NM, MH, JAC); the Mental Health Department, Parc Taulí Sabadell, Universitat Autònoma de Barcelona (NC); the Radiology Department, MRI Research Unit, Hospital del Mar, Barcelona (JP); Sant Joan de Déu Barcelona-Children's Hospital, Barcelona (EV); and the Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona (CS-M).
Abstract
OBJECTIVE: The selection of a bitemporal (BT) or right unilateral (RUL) electrode placement affects the efficacy and side effects of ECT. Previous studies have not entirely described the neurobiological underpinnings of such differential effects. Recent neuroimaging research on gray matter volumes is contributing to our understanding of the mechanism of action of ECT and could clarify the differential mechanisms of BT and RUL ECT. METHODS: To assess the whole-brain gray matter volumetric changes observed after treating patients with treatment-resistant depression with BT or RUL ECT, the authors used MRI to assess 24 study subjects with treatment-resistant depression (bifrontotemporal ECT, N=12; RUL ECT, N=12) at two time points (before the first ECT session and after ECT completion). RESULTS: Study subjects receiving BT ECT showed gray matter volume increases in the bilateral limbic system, but subjects treated with RUL ECT showed gray matter volume increases limited to the right hemisphere. The authors observed significant differences between the two groups in midtemporal and subcortical limbic structures in the left hemisphere. CONCLUSIONS: These findings highlight that ECT-induced gray matter volume increases may be specifically observed in the stimulated hemispheres. The authors suggest that electrode placement may relevantly contribute to the development of personalized ECT protocols.
OBJECTIVE: The selection of a bitemporal (BT) or right unilateral (RUL) electrode placement affects the efficacy and side effects of ECT. Previous studies have not entirely described the neurobiological underpinnings of such differential effects. Recent neuroimaging research on gray matter volumes is contributing to our understanding of the mechanism of action of ECT and could clarify the differential mechanisms of BT and RUL ECT. METHODS: To assess the whole-brain gray matter volumetric changes observed after treating patients with treatment-resistant depression with BT or RUL ECT, the authors used MRI to assess 24 study subjects with treatment-resistant depression (bifrontotemporal ECT, N=12; RUL ECT, N=12) at two time points (before the first ECT session and after ECT completion). RESULTS: Study subjects receiving BT ECT showed gray matter volume increases in the bilateral limbic system, but subjects treated with RUL ECT showed gray matter volume increases limited to the right hemisphere. The authors observed significant differences between the two groups in midtemporal and subcortical limbic structures in the left hemisphere. CONCLUSIONS: These findings highlight that ECT-induced gray matter volume increases may be specifically observed in the stimulated hemispheres. The authors suggest that electrode placement may relevantly contribute to the development of personalized ECT protocols.
Authors: Won Hee Lee; Zhi-De Deng; Tae-Seong Kim; Andrew F Laine; Sarah H Lisanby; Angel V Peterchev Journal: Neuroimage Date: 2011-10-18 Impact factor: 6.556
Authors: Malte S Depping; Henrike M Nolte; Dusan Hirjak; Elisa Palm; Stefan Hofer; Bram Stieltjes; Klaus Maier-Hein; Fabio Sambataro; Robert C Wolf; Philipp A Thomann Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2016-09-22 Impact factor: 5.067
Authors: Indira Tendolkar; Marleen van Beek; Iris van Oostrom; Marlies Mulder; Joost Janzing; Richard Oude Voshaar; Philip van Eijndhoven Journal: Psychiatry Res Date: 2013-10-03 Impact factor: 3.222
Authors: Leif Oltedal; Katherine L Narr; Christopher Abbott; Amit Anand; Miklos Argyelan; Hauke Bartsch; Udo Dannlowski; Annemieke Dols; Philip van Eijndhoven; Louise Emsell; Vera Jane Erchinger; Randall Espinoza; Tim Hahn; Lars G Hanson; Gerhard Hellemann; Martin Balslev Jorgensen; Ute Kessler; Mardien L Oudega; Olaf B Paulson; Ronny Redlich; Pascal Sienaert; Max L Stek; Indira Tendolkar; Mathieu Vandenbulcke; Ketil J Oedegaard; Anders M Dale Journal: Biol Psychiatry Date: 2018-05-29 Impact factor: 13.382
Authors: M Cano; I Martínez-Zalacaín; Á Bernabéu-Sanz; O Contreras-Rodríguez; R Hernández-Ribas; E Via; A de Arriba-Arnau; V Gálvez; M Urretavizcaya; J Pujol; J M Menchón; N Cardoner; C Soriano-Mas Journal: Transl Psychiatry Date: 2017-02-07 Impact factor: 6.222
Authors: Miklos Argyelan; Leif Oltedal; Zhi-De Deng; Benjamin Wade; Marom Bikson; Andrea Joanlanne; Sohag Sanghani; Hauke Bartsch; Marta Cano; Anders M Dale; Udo Dannlowski; Annemiek Dols; Verena Enneking; Randall Espinoza; Ute Kessler; Katherine L Narr; Ketil J Oedegaard; Mardien L Oudega; Ronny Redlich; Max L Stek; Akihiro Takamiya; Louise Emsell; Filip Bouckaert; Pascal Sienaert; Jesus Pujol; Indira Tendolkar; Philip van Eijndhoven; Georgios Petrides; Anil K Malhotra; Christopher Abbott Journal: Elife Date: 2019-10-23 Impact factor: 8.140
Authors: Olga Therese Ousdal; Giulio E Brancati; Ute Kessler; Vera Erchinger; Anders M Dale; Christopher Abbott; Leif Oltedal Journal: Biol Psychiatry Date: 2021-05-31 Impact factor: 13.382
Authors: Nils Opel; Katherine L. Narr; Christopher Abbott; Miklos Argyelan; Randall Espinoza; Louise Emsell; Filip Bouckaert; Pascal Sienaert; Mathieu Vandenbulcke; Pia Nordanskog; Jonathan Repple; Erhan Kavakbasi; Martin B. Jorgensen; Olaf B. Paulson; Lars G. Hanson; Annemieke Dols; Eric van Exel; Mardien L. Oudega; Akihiro Takamiya; Taishiro Kishimoto; Olga Therese Ousdal; Jan Haavik; Åsa Hammar; Ketil Joachim Oedegaard; Ute Kessler; Hauke Bartsch; Anders M. Dale; Bernhard T. Baune; Udo Dannlowski; Leif Oltedal; Ronny Redlich Journal: J Psychiatry Neurosci Date: 2021-07-05 Impact factor: 6.186